NDC 0002-8233 – Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen
Insulin Lispro 100 [iU]/mL · Injection, Suspension · Subcutaneous
Product NDC0002-8233
Product details
- Brand name
- Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen
- Generic name
- Insulin lispro
- Labeler
- Eli Lilly and Company
- Dosage form
- Injection, Suspension
- Route
- Subcutaneous
- Marketing category
- BLA · BLA021017
- Marketed since
- February 12, 2020
- Listing expires
- December 31, 2026
- Pharmacologic class
- Insulin Analog
Active ingredients
- Insulin Lispro 100 [iU]/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0002-8233-05 | 5 SYRINGE in 1 CARTON (0002-8233-05) / 3 mL in 1 SYRINGE (0002-8233-01) | Feb 12, 2020 |